Diabetic Retinopathy

Prim Care. 2015 Sep;42(3):451-64. doi: 10.1016/j.pop.2015.05.005.

Abstract

The prevalence of diabetes is on the rise globally as are the consequences, such as diabetic retinopathy. Diabetic retinopathy is a leading cause of vision loss in working-age adults in developed countries. Visual impairment as a result of diabetic retinopathy has a significant negative impact on the patient's quality of life and their ability to successfully manage their disease. Glycemic control, blood pressure normalization, and lipid management form the basis for long-term diabetes management and protection from worsening eye disease.

Keywords: Diabetic retinopathy; Glycemic control; Nonproliferative diabetic retinopathy; Proliferative diabetic retinopathy; Visual impairment.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Angiogenesis Inhibitors / therapeutic use
  • Blood Glucose
  • Diabetic Retinopathy / epidemiology*
  • Diabetic Retinopathy / physiopathology
  • Diabetic Retinopathy / therapy
  • Dyslipidemias / drug therapy
  • Dyslipidemias / epidemiology
  • Exercise
  • Humans
  • Hypertension / drug therapy
  • Hypertension / epidemiology
  • Intravitreal Injections
  • Light Coagulation
  • Macular Edema / epidemiology
  • Mass Screening
  • Platelet Aggregation Inhibitors / therapeutic use
  • Prevalence
  • Primary Health Care*
  • Quality of Life
  • Referral and Consultation*
  • Risk Factors
  • Smoking / epidemiology
  • Vitrectomy

Substances

  • Adrenal Cortex Hormones
  • Angiogenesis Inhibitors
  • Blood Glucose
  • Platelet Aggregation Inhibitors